Skip to main content
. 2022 Feb 16;40(8):1180–1189. doi: 10.1016/j.vaccine.2021.11.061

Fig. 4.

Fig. 4

Adjusted hazard ratios (95% confidence interval) for BNT162b2 vaccine effectiveness against PCR-confirmed COVID-19 infection for (A) first dose weeks 3–6, (B) second dose weeks 2–5 and (C) weeks 22–25. All cases were vaccinated between 7 December 2020 and 30 September 2021. Estimates shown are relative to the same characteristic unvaccinated.